Hemostemix

Hemostemix (HMTXF) has contracted Empire Market Ventures (EMV) to boost its market awareness. EMV, a New York-based consulting firm specializing in investor relations and strategic communications, will develop and implement investor engagement strategies using digital media and market intelligence. EMV will operate independently to provide unbiased counsel and ensure regulatory compliance. The goal of the partnership is to increase Hemostemix’s visibility and growth within the capital markets. The announcement was made on August 12, 2025.